Advertisement
News
Subscribe to MDT Magazine News

La Jolla Institute to develop San Diego's first center for RNAi genomics research

October 8, 2010 2:33 pm | by EurekAlert | Comments

(La Jolla Institute for Allergy and Immunology) The La Jolla Institute for Allergy and Immunology will develop San Diego's first Center for RNAi screening -- a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and...

TOPICS:

CDRH & #8217;s New Inspections Database Can Be Resource for Devicemakers

October 8, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

Devicemakers have a new tool to help them find suitable vendors — a CDRH database that provides information about device inspections from 2008 to the present.

Chronic Disease Alliance receives European Health Award 2010

October 8, 2010 1:36 pm | by EurekAlert | Comments

(European Society of Cardiology) The European Society of Cardiology is delighted to see the European Health Award 2010 handed to the Chronic Disease Alliance at the 13th European Health Forum held in Gastein October 6-9, 2010.

TOPICS:
Advertisement

Bruker closes $229M buyout of Veeco instruments biz

October 8, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Medical technology developer Bruker Corp. has completed its $229.4 million cash acquisition of the Veeco Instruments Inc.'s Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses.

MoMelan moves skin graft device toward commercialization

October 8, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based medical device company MoMelan Technologies is hurtling towards commercialization of a device designed to stretch skin – improving the cost, time and patient experience of skin graft procedures.

Meridia (sibutramine): Market Withdrawal Due to Risk of Serious Cardiovascular Events

October 8, 2010 10:34 am | by U.S. Food & Drug Administration | Comments

Action based on data from clinical trial showing 16% increased risk of serious heart events.

Slimming Beauty Bitter Orange Slimming Capsules: Undeclared Drug Ingredient

October 8, 2010 10:33 am | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement contains sibutramine, which can lead to elevated blood pressure, stroke, or heart attack.

LHC plans earnings report on Nov. 1

October 8, 2010 9:45 am | by The Associated Press | Comments

LHC Group, the Lafayette-based provider of home health and hospice services, said Friday that it will report its earnings for the quarter and nine months ended Sept. 30 on Nov. 1.The company said the report will be released after the close of U.S. financial markets.

Advertisement

Z-Medica signs deal to sell blood clot product in Belgium

October 8, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Z-Medica Corp., a Wallingford, Conn.-based medical products maker, has signed a deal that gives Belgian medical device distribution firm Romed NV exclusive sales and distribution rights of its QuikClot hemostatic products in Belgium.

Virginian-Pilot Story Misleads Readers on USDA Inspection Report for PLRS

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

CORAPEAKE, N.C., Oct. 8 /- Contrary to a report in today's Virginian-Pilot , a comprehensive inspection by the U.S. Department of Agriculture (USDA) of NC-based Professional Laboratory and Research Services (PLRS) has found no evidence of animal neglect or abuse. The USDA finding follows...

TOPICS:

Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Oct. 8 /PRNewswire-USNewswire/ -- Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) from the U.S. market because of clinical trial data indicating an increased risk of heart attack and stroke, the U.S. Food and Drug...

TOPICS:

Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

CLEVELAND, Oct. 8 /- Synapse Biomedical Inc . announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS)™ as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis ( ALS ) patients with a...

TOPICS:

Pioneer® Surgical Technology, Inc. Announces Agreement to Acquire Exclusive Access to the Cequence™ Cervical Plate System From SpineSmith, LP

October 8, 2010 9:31 am | by Bio-Medicine.Org | Comments

MARQUETTE, Mich., Oct. 8 /- Pioneer Surgical Technology, Inc. and SpineSmith, LP are pleased to announce a deal in which Pioneer Surgical will acquire exclusive rights to manufacture and distribute the Cequence™ anterior cervical plate.  As part of the agreement, Pioneer...

TOPICS:

Life cycle of adult hippocampal newborn neuron uncovered

October 8, 2010 8:32 am | by Baylor College of Medicine | Comments

Unlocking the mystery of neurological disorders starts with understanding how neurons are generated and maintained. Recently, researchers at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and Baylor College of Medicine discovered that the life cycle of...

TOPICS:

Empowerment fair offers opportunities for women with disabilities

October 8, 2010 8:32 am | by Baylor College of Medicine | Comments

Baylor College of Medicine's Center for Research on Women with Disabilities and the Houston Center for Independent Living will host the first annual Women with Disabilities Empowerment Fair on Saturday, Oct. 30, at 2 p.m. at the Metropolitan Multi-Service Center, 1475 West Gray Street....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading